Inclusion body myositis: The interplay between ageing, muscle degeneration and autoimmunity
- PMID: 35760741
- DOI: 10.1016/j.berh.2022.101761
Inclusion body myositis: The interplay between ageing, muscle degeneration and autoimmunity
Abstract
Inclusion body myositis (IBM) is a slowly progressive muscle disease affecting ageing individuals. IBM presents with a distinctive pattern of weakness involving the quadriceps and finger flexor muscles, although other muscles including pharyngeal muscles become affected over time. Pathological hallmarks of IBM include autoimmune features, including endomysial infiltration by highly differentiated T cells, as well as degenerative features marked by intramyofibre protein aggregates organised into inclusion bodies. Despite some progress in understanding the cellular pathways involved in IBM, it remains untreatable, and the progression of the disease leads to progressive weakness, disability, wheelchair dependency and loss of independence. Therefore, there is an urgent need to improve our understanding of the underlying mechanisms and pathways involved in this disease to identify new treatment targets. Here, we discuss the current understanding of aetiopathogenesis, the interrelationship between autoimmunity and degeneration, and how ageing is a major influencer of both these features.
Keywords: Ageing; Autoimmunity; Inclusion body myositis; Myodegeneration; Pathogenesis.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Similar articles
-
Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging.Int J Mol Sci. 2024 Feb 27;25(5):2742. doi: 10.3390/ijms25052742. Int J Mol Sci. 2024. PMID: 38473988 Free PMC article. Review.
-
Inclusion body myositis: clinical features and pathogenesis.Nat Rev Rheumatol. 2019 May;15(5):257-272. doi: 10.1038/s41584-019-0186-x. Nat Rev Rheumatol. 2019. PMID: 30837708 Review.
-
Inclusion body myositis: Update on the diagnostic and therapeutic landscape.Front Neurol. 2022 Sep 27;13:1020113. doi: 10.3389/fneur.2022.1020113. eCollection 2022. Front Neurol. 2022. PMID: 36237625 Free PMC article. Review.
-
[Sporadic Inclusion Body Myositis].Brain Nerve. 2023 Jul;75(7):869-874. doi: 10.11477/mf.1416202433. Brain Nerve. 2023. PMID: 37431078 Japanese.
-
Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis.Neuromuscul Disord. 2023 Feb;33(2):169-182. doi: 10.1016/j.nmd.2022.12.001. Epub 2022 Dec 5. Neuromuscul Disord. 2023. PMID: 36649672
Cited by
-
Old muscle, new tricks: a clinician perspective on sarcopenia and where to next.Curr Opin Neurol. 2023 Oct 1;36(5):441-449. doi: 10.1097/WCO.0000000000001185. Epub 2023 Jul 24. Curr Opin Neurol. 2023. PMID: 37501556 Free PMC article. Review.
-
Intramyocardial fatty infiltration lesion in sporadic inclusion body myositis: a case report.Int J Cardiovasc Imaging. 2024 Oct 28. doi: 10.1007/s10554-024-03271-z. Online ahead of print. Int J Cardiovasc Imaging. 2024. PMID: 39466494
-
Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models.Clin Transl Immunology. 2024 Apr 3;13(4):e1504. doi: 10.1002/cti2.1504. eCollection 2024. Clin Transl Immunology. 2024. PMID: 38585335 Free PMC article.
-
Muscle mass dynamics is independently associated with long-term liver-related mortality in patients with cirrhosis.Heliyon. 2024 Aug 3;10(15):e35354. doi: 10.1016/j.heliyon.2024.e35354. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170308 Free PMC article.
-
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis.Acta Neuropathol. 2023 Nov;146(5):725-745. doi: 10.1007/s00401-023-02637-2. Epub 2023 Sep 29. Acta Neuropathol. 2023. PMID: 37773216 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical